Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 21, 2014; 20(3): 613-629
Published online Jan 21, 2014. doi: 10.3748/wjg.v20.i3.613
Published online Jan 21, 2014. doi: 10.3748/wjg.v20.i3.613
Table 1 Autoimmune diseases or autoimmune disease-related disorders which have been studied for their possible (direct or indirect) relation with Helicobacter pylori infection
| AID or AID-related disorders linked to H. pylori | AID or AID-related disorders linked to H. pylori | ||
| 1 | Alopecia areata | 49 | Juvenile diabetes (Type 1 diabetes) |
| 2 | Antiphospholipid syndrome | 50 | Kawasaki syndrome |
| 3 | Autoimmune angioedema | 51 | Leukocytoclastic vasculitis |
| 4 | Autoimmune hepatitis | 52 | Lichen planus |
| 5 | Autoimmune hyperlipidemia | 53 | Linear IgA disease |
| 6 | Autoimmune hemolytic anemia | 54 | Lupus (SLE) |
| 7 | Autoimmune myocarditis | 55 | Microscopic polyangiitis |
| 8 | Autoimmune oophoritis | 56 | Mixed connective tissue disease |
| 9 | Autoimmune pancreatitis | 57 | Mooren’s ulcer |
| 10 | Autoimmune polyglandular syndromes | 58 | Multiple sclerosis |
| 11 | Autoimmune thrombocytopenic purpura | 59 | Myositis |
| 12 | Autoimmune thyroid disease | 60 | Narcolepsy |
| 13 | Autoimmune urticaria | 61 | Neuromyelitis optica (Devic’s) |
| 14 | Axonal and neuronal neuropathies | 62 | Neutropenia |
| 15 | Behcet’s disease | 63 | Ocular cicatricial pemphigoid |
| 16 | Bullous pemphigoid | 64 | Optic neuritis |
| 17 | Cardiomyopathy | 65 | Palindromic rheumatism |
| 18 | Celiac disease | 66 | Pars planitis (peripheral uveitis) |
| 19 | Chagas disease | 67 | Pemphigus |
| 20 | Chronic inflammatory demyelinating polyneuropathy | 68 | Peripheral neuropathy |
| 21 | Chronic recurrent multifocal osteomyelitis | 69 | Perivenous encephalomyelitis |
| 22 | Crohn’s disease | 70 | Pernicious anemia |
| 23 | Cogans syndrome | 71 | Polyarteritis nodosa |
| 24 | Demyelinating neuropathies | 72 | Polymyalgia rheumatica |
| 25 | Dermatitis herpetiformis | 73 | Polymyositis |
| 26 | Dermatomyositis | 74 | Primary biliary cirrhosis |
| 27 | Devic’s disease (neuromyelitis optica) | 75 | Primary sclerosing cholangitis |
| 28 | Eosinophilic esophagitis | 76 | Psoriasis |
| 29 | Eosinophilic fasciitis | 77 | (Idiopathic) pulmonary fibrosis |
| 30 | Erythema nodosum | 78 | Pyoderma gangrenosum |
| 31 | Experimental allergic encephalomyelitis | 79 | Raynaud’s phenomenon |
| 32 | Fibromyalgia | 80 | Reactive Arthritis |
| 33 | Fibrosing alveolitis | 81 | Reiter’s syndrome |
| 34 | Giant cell arteritis (temporal arteritis) | 82 | Relapsing polychondritis |
| 35 | Giant cell myocarditis | 83 | Rheumatoid arthritis |
| 36 | Glomerulonephritis | 84 | Sarcoidosis |
| 37 | Goodpasture’s syndrome | 85 | Scleroderma (systemic sclerosis) |
| 38 | Graves’ disease | 86 | Sjogren’s syndrome |
| 39 | Guillain-Barre syndrome | 87 | Temporal arteritis/Giant cell arteritis |
| 40 | Hashimoto’s thyroiditis | 88 | Thrombocytopenic purpura |
| 41 | Henoch-Schonlein purpura | 89 | Transverse myelitis |
| 42 | Hypogammaglobulinemia idiopathic thrombocytopenic purpura | 90 | Type 1 diabetes |
| 43 | IgA nephropathy | 91 | Ulcerative colitis |
| 44 | IgG4-related sclerosing disease | 92 | Undifferentiated connective tissue disease |
| 45 | Immunoregulatory lipoproteins | 93 | Uveitis |
| 46 | Inclusion body myositis | 94 | Vasculitis (other forms) |
| 47 | Interstitial cystitis | 95 | Vesiculobullous dermatosis |
| 48 | Juvenile arthritis |
Table 2 Autoimmune diseases or autoimmune diseases-related disorders which have not been studied for their possible (direct or indirect) relation with Helicobacter pylori infection
| AID or AID-related disorders not linked to H. pylori | |
| 1 | Acute Disseminated Encephalomyelitis |
| 2 | Acute necrotizing hemorrhagic leukoencephalitis |
| 3 | Addison's disease |
| 4 | Agammaglobulinemia |
| 5 | Amyloidosis |
| 6 | Ankylosing spondylitis |
| 7 | Anti-GBM/Anti-TBM nephritis |
| 8 | Autoimmune aplastic anemia |
| 9 | Autoimmune dysautonomia |
| 10 | Autoimmune immunodeficiency |
| 11 | Autoimmune inner ear disease |
| 12 | Autoimmune retinopathy |
| 13 | Balo disease |
| 14 | Castleman disease |
| 15 | Chronic fatigue syndrome |
| 16 | Churg-Strauss syndrome |
| 17 | Cicatricial pemphigoid/benign mucosal pemphigoid |
| 18 | Congenital heart block |
| 19 | Coxsackie myocarditis |
| 20 | CREST disease |
| 21 | Essential mixed cryoglobulinemia |
| 22 | Discoid lupus |
| 23 | Dressler’s syndrome |
| 24 | Endometriosis |
| 25 | Evans syndrome |
| 26 | Granulomatosis with Polyangiitis (formerly called Wegener’s Granulomatosis) |
| 27 | Hashimoto’s encephalitis |
| 28 | Herpes gestationis |
| 29 | Juvenile myositis |
| 30 | Lambert-Eaton syndrome |
| 31 | Lichen sclerosus |
| 32 | Ligneous conjunctivitis |
| 33 | Lyme disease, |
| 34 | (Chronic) Meniere’s disease |
| 35 | Mucha-Habermann disease |
| 36 | Myasthenia gravis |
| 37 | Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus |
| 38 | Paraneoplastic cerebellar degeneration |
| 39 | Paroxysmal nocturnal hemoglobinuria |
| 40 | Parry Romberg syndrome |
| 41 | Parsonage-Turner syndrome |
| 42 | POEMS syndrome |
| 43 | Postmyocardial infarction syndrome |
| 44 | Postpericardiotomy syndrome |
| 45 | Progesterone dermatitis |
| 46 | Psoriatic arthritis |
| 47 | Pure red cell aplasia |
| 48 | Reflex sympathetic dystrophy |
| 49 | Restless legs syndrome |
| 50 | Retroperitoneal fibrosis |
| 51 | Rheumatic fever |
| 52 | Schmidt syndrome |
| 53 | Scleritis |
| 54 | Sperm and testicular autoimmunity |
| 55 | Stiff person syndrome |
| 56 | Subacute bacterial endocarditis |
| 57 | Susac’s syndrome |
| 58 | Sympathetic ophthalmia |
| 59 | Takayasu’s arteritis |
| 60 | Tolosa-Hunt syndrome |
| 61 | Vitiligo |
Table 3 Evidence in support or against the role of Helicobacter pylori in autoimmune disease
| Autoimmune condition | Evidence in support and/or against the role of H. pylori | Overall opinion |
| SjS | Support: | Inconclusive |
| Oral cavity populated with H. pylori | ||
| Higher level of anti-H. pylori antibodies in SjS patients | ||
| Increased incidence of mucosal associated lymphoid tissue and lymphomas in parotid and lacrimal glands of SjS patients | ||
| Against: | ||
| Low levels of anti-H. pylori antibodies in SjS patients compared to controls | ||
| SSc | Support: | Inconclusive |
| Higher incidence of H. pylori antibodies in SSc patients than controls | ||
| H. pylori eradication improves Raynaud's in SSc patients | ||
| Possible protective role against Barrett's esophagus | ||
| Higher level of CagA strain H. pylori infected patients | ||
| Against: | ||
| Low incidence of anti-H. pylori antibodies compared to controls | ||
| RA | Support: | Unlikely |
| Increased rheumatoid factor IgM from B cells chronically stimulated with H. pylori urease | ||
| Against: | ||
| Low prevalence of anti-H. pylori in RA patients | ||
| Unchanged clinical course or symptomatology after H. pylori eradication | ||
| SLE | Support: | Unlikely |
| H. pylori urease exposure induced anti-ssDNA antibody production in an animal model of SLE | ||
| Against: | ||
| Low levels of anti-H. pylori found among SLE patients, at levels comparable to controls | ||
| Negative association between H. pylori seropositivity and the development of SLE in African-American women | ||
| ITP | Support: | Probable |
| Improvement of platelet counts following H. pylori eradication (CagA type H. pylori in particular) | ||
| Anti-CagA antibodies cross-react with peptides on platelets of ITP patient | ||
| Platelet associated IgGs declined following H. pylori eradication | ||
| Found in high prevalence in some ITP cohorts | ||
| Platelet eluates from ITP patients recognize H. pylori CagA | ||
| Against: | ||
| Low levels of H. pylori found in ITP patients | ||
| AiTD | Support: | Probable in Graves’ disease |
| Higher seropositivity and positive stool cultures for H. pylori in Graves’ disease patients | ||
| CagA strain predominant among Graves’ disease patients | ||
| Amino acid similarities between CagA and thyroid peroxidase | ||
| Reduction in anti-thyroid antibodies following H. pylori eradication | ||
| Against: | Unlikely in Hashimoto’s thyroiditis | |
| Low levels of infection among Hashimoto’s thyroiditis patients | ||
| MS and NMO | Support: | Probable in NMO |
| High rate of H. pylori infection among NMO patients | ||
| Correlation between H. pylori infection and presence of aquaporin-4 antibodies | ||
| Against: | Unlikely in MS | |
| H. pylori infection rates in MS patients similar to or lower than control groups | ||
| Psoriasis | Support: | Probable |
| Higher levels of anti-H. pylori antibodies in patients | ||
| Appears to be correlation between H. pylori infection and disease severity | ||
| Clinical improvement following H. pylori eradication | ||
| Against: | ||
| No difference in anti-H. pylori levels compared to controls | ||
| No difference of CagA seropositivity between patients and controls | ||
| Behçet’s disease | Support: | Unlikely |
| Higher infection prevalence in patients | ||
| Some clinical improvement noted after eradication | ||
| Against: | ||
| No difference between patients and controls | ||
| Alopecia areata | Support: | Unlikely |
| Higher infection prevalence | ||
| Against: | ||
| No difference in infection prevalence between patients and controls | ||
| PBC | Support: | Unlikely |
| Higher prevalence of anti-H. pylori antibodies among PBC patients | ||
| Amino acid similarities between pyruvate dehydrogenase E2 (PDC-E2) and urease beta of H. pylori | ||
| Against: | ||
| No differences of infection found between patients and controls | ||
| No immunological cross reactivities at the B or CD4 T-cell level | ||
| No crossreactivity between H. pylori VacA and PDC-E2 | ||
| AIH | Support: | Unlikely |
| No current evidence | ||
| Against: | ||
| No differences in anti-H. pylori antibodies between patients and controls | ||
| No significant difference between H. pylori in liver tissues in patients compared to controls | ||
| PSC | Support: | Unlikely |
| Detectable H. pylori DNA in PSC liver samples | ||
| CagA in samples from PSC patients | ||
| Concomitant ulcerative colitis may be related to H. pylori translocation from the gut to the liver | ||
| Against: | ||
| No difference in H. pylori prevalence among pediatric or adult PSC patients compared to controls | ||
| No significant difference between H. pylori in liver tissues in patients compared to controls |
-
Citation: Smyk DS, Koutsoumpas AL, Mytilinaiou MG, Rigopoulou EI, Sakkas LI, Bogdanos DP.
Helicobacter pylori and autoimmune disease: Cause or bystander. World J Gastroenterol 2014; 20(3): 613-629 - URL: https://www.wjgnet.com/1007-9327/full/v20/i3/613.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i3.613
